181 related articles for article (PubMed ID: 31817217)
1. The Impact of Solvent Selection: Strategies to Guide the Manufacturing of Liposomes Using Microfluidics.
Webb C; Khadke S; Schmidt ST; Roces CB; Forbes N; Berrie G; Perrie Y
Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31817217
[TBL] [Abstract][Full Text] [Related]
2. The effect of different organic solvents in liposome properties produced in a periodic disturbance mixer: Transcutol®, a potential organic solvent replacement.
López RR; G Font de Rubinat P; Sánchez LM; Tsering T; Alazzam A; Bergeron KF; Mounier C; Burnier JV; Stiharu I; Nerguizian V
Colloids Surf B Biointerfaces; 2021 Feb; 198():111447. PubMed ID: 33223347
[TBL] [Abstract][Full Text] [Related]
3. Rapid scale-up and production of active-loaded PEGylated liposomes.
Roces CB; Port EC; Daskalakis NN; Watts JA; Aylott JW; Halbert GW; Perrie Y
Int J Pharm; 2020 Aug; 586():119566. PubMed ID: 32622812
[TBL] [Abstract][Full Text] [Related]
4. Rapid and scale-independent microfluidic manufacture of liposomes entrapping protein incorporating in-line purification and at-line size monitoring.
Forbes N; Hussain MT; Briuglia ML; Edwards DP; Horst JHT; Szita N; Perrie Y
Int J Pharm; 2019 Feb; 556():68-81. PubMed ID: 30503269
[TBL] [Abstract][Full Text] [Related]
5. Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs.
Joshi S; Hussain MT; Roces CB; Anderluzzi G; Kastner E; Salmaso S; Kirby DJ; Perrie Y
Int J Pharm; 2016 Nov; 514(1):160-168. PubMed ID: 27863660
[TBL] [Abstract][Full Text] [Related]
6. How docetaxel entrapment, vesicle size, zeta potential and stability change with liposome composition-A formulation screening study.
Holsæter AM; Wizgird K; Karlsen I; Hemmingsen JF; Brandl M; Škalko-Basnet N
Eur J Pharm Sci; 2022 Oct; 177():106267. PubMed ID: 35872073
[TBL] [Abstract][Full Text] [Related]
7. Precise control of liposome size using characteristic time depends on solvent type and membrane properties.
Choi S; Kang B; Yang E; Kim K; Kwak MK; Chang PS; Jung HS
Sci Rep; 2023 Mar; 13(1):4728. PubMed ID: 36959258
[TBL] [Abstract][Full Text] [Related]
8. Rapid optimization of liposome characteristics using a combined microfluidics and design-of-experiment approach.
Sedighi M; Sieber S; Rahimi F; Shahbazi MA; Rezayan AH; Huwyler J; Witzigmann D
Drug Deliv Transl Res; 2019 Feb; 9(1):404-413. PubMed ID: 30306459
[TBL] [Abstract][Full Text] [Related]
9. High-throughput manufacturing of size-tuned liposomes by a new microfluidics method using enhanced statistical tools for characterization.
Kastner E; Kaur R; Lowry D; Moghaddam B; Wilkinson A; Perrie Y
Int J Pharm; 2014 Dec; 477(1-2):361-8. PubMed ID: 25455778
[TBL] [Abstract][Full Text] [Related]
10. Liposome production by microfluidics: potential and limiting factors.
Carugo D; Bottaro E; Owen J; Stride E; Nastruzzi C
Sci Rep; 2016 May; 6():25876. PubMed ID: 27194474
[TBL] [Abstract][Full Text] [Related]
11. Using microfluidics for scalable manufacturing of nanomedicines from bench to GMP: A case study using protein-loaded liposomes.
Webb C; Forbes N; Roces CB; Anderluzzi G; Lou G; Abraham S; Ingalls L; Marshall K; Leaver TJ; Watts JA; Aylott JW; Perrie Y
Int J Pharm; 2020 May; 582():119266. PubMed ID: 32251694
[TBL] [Abstract][Full Text] [Related]
12. The impact of solvent selection on the characteristics of niosome nanoparticles prepared by microfluidic mixing.
Obeid MA; Haifawi S; Khadra I
Int J Pharm X; 2023 Dec; 5():100168. PubMed ID: 36852395
[TBL] [Abstract][Full Text] [Related]
13. Microfluidic synthesis of PEG- and folate-conjugated liposomes for one-step formation of targeted stealth nanocarriers.
Hood RR; Shao C; Omiatek DM; Vreeland WN; DeVoe DL
Pharm Res; 2013 Jun; 30(6):1597-607. PubMed ID: 23386106
[TBL] [Abstract][Full Text] [Related]
14. Scalable solvent-free production of liposomes.
Khadke S; Roces CB; Donaghey R; Giacobbo V; Su Y; Perrie Y
J Pharm Pharmacol; 2020 Oct; 72(10):1328-1340. PubMed ID: 32671856
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of liposome formulation parameters and their influence on encapsulation, stability and drug release in glibenclamide liposomes.
Maritim S; Boulas P; Lin Y
Int J Pharm; 2021 Jan; 592():120051. PubMed ID: 33161039
[TBL] [Abstract][Full Text] [Related]
16. Manufacturing drug co-loaded liposomal formulations targeting breast cancer: Influence of preparative method on liposomes characteristics and in vitro toxicity.
Gkionis L; Campbell RA; Aojula H; Harris LK; Tirella A
Int J Pharm; 2020 Nov; 590():119926. PubMed ID: 33010397
[TBL] [Abstract][Full Text] [Related]
17. Microfluidic-assisted fabrication of phosphatidylcholine-based liposomes for controlled drug delivery of chemotherapeutics.
Gkionis L; Aojula H; Harris LK; Tirella A
Int J Pharm; 2021 Jul; 604():120711. PubMed ID: 34015381
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Characterization of Paclitaxel-Loaded PEGylated Liposomes by the Microfluidics Method.
Jaradat E; Weaver E; Meziane A; Lamprou DA
Mol Pharm; 2023 Dec; 20(12):6184-6196. PubMed ID: 37931072
[TBL] [Abstract][Full Text] [Related]
19. Microfluidic preparation of drug-loaded PEGylated liposomes, and the impact of liposome size on tumour retention and penetration.
Dong YD; Tchung E; Nowell C; Kaga S; Leong N; Mehta D; Kaminskas LM; Boyd BJ
J Liposome Res; 2019 Mar; 29(1):1-9. PubMed ID: 29020849
[TBL] [Abstract][Full Text] [Related]
20. Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations.
Ballacchino G; Weaver E; Mathew E; Dorati R; Genta I; Conti B; Lamprou DA
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
